In this randomized clinical trial, 80 subclinical hypothyroidism patients with normal serum concentrations of FT4 and TSH range of 5.2-10 mIU/L referring to endocrine clinic of Shahid Beheshti Hospital of Qom are studied. Then the patients are randomly divided into control and case groups. For the case group, levothyroxine treatment will be initiated and the control group will receive no medications.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2014051417686N1
Registration date:2014-08-29, 1393/06/07
Registration timing:retrospective
Last update:
Update count:0
Registration date
2014-08-29, 1393/06/07
Registrant information
Name
Mahmoud Parham
Name of organization / entity
Qom University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 25 3612 2949
Email address
drparham@muq.ac.ir
Recruitment status
Recruitment complete
Funding source
Qom University of Medical Sciences
Expected recruitment start date
2013-03-21, 1392/01/01
Expected recruitment end date
2013-06-21, 1392/03/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of levothyroxine on serum lipids in patients with subclinical hypothyroidism
Public title
Effect of levothyroxine on serum lipids in patients with subclinical hypothyroidism
Qom- Saheli Streeet-Qom University of Medical Sciences
City
Qom
Postal code
3719764799
Approval date
2012-10-10, 1391/07/19
Ethics committee reference number
11235/34/پ
Health conditions studied
1
Description of health condition studied
Hypothyroidism
ICD-10 code
E02
ICD-10 code description
Subclinical iodine-deficiency hypothyroidism
Primary outcomes
1
Description
LDL
Timepoint
0 and 3 months later
Method of measurement
mg/dL
2
Description
HDL
Timepoint
0 and 3 months later
Method of measurement
mg/dL
3
Description
TG
Timepoint
0 and 3 months later
Method of measurement
mg/dL
4
Description
TSH
Timepoint
0 and 3 months later
Method of measurement
mIU/L
5
Description
T4
Timepoint
0 and 3 months later
Method of measurement
ng/dL
6
Description
Cholesterol
Timepoint
0 and 3 months later
Method of measurement
mg/dL
Secondary outcomes
empty
Intervention groups
1
Description
In the case group Levothyroxine sodium (brand name Levoxin) tablet manufactured by Iran hormone pharmaceutical company with dose of 50 microgramg is used once a day for 3 months